SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy.
Lova L SunSanjna SuryaNoah G GoodmanAnh N LeGregory KellyOlutosin OwoyemiHeena DesaiCathy ZhengShannon DeLucaMadeline L GoodJasmin HussainSeth D JeffriesYolanda R KryEmily M KuglerMaikel MansourJohn NdicuAnnaClaire Osei-AkotoTimothy PriorStacy L PundockLisa A VarugheseJoEllen WeaverAbigail DoucetteScott DudekShefali Setia VermaSigrid GoumaMadison E WeirickChristopher M McAllisterErin M BangePeter E GabrielMarylyn DeRiggi RitchieDaniel James RaderRobert H VonderheideLynn M SchuchterAnurag VermaIvan P MaillardRonac MamtaniScott E HensleyRobert GrossE Paul WileytoAlexander C HuangKara N MaxwellAngela M DeMichelePublished in: JCO oncology practice (2021)
These results suggest that patients with cancer receiving in-person care at a facility with aggressive mitigation efforts have an extremely low likelihood of COVID-19 infection.